Pre-existing fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/5347

Title:	Pre-existing fas ligand (FasL) in cancer cells elicits tumor-specific protective immunity, but delayed induction of FasL expression after inoculation facilitates tumor formation
Authors:	Chiu, H. Y. Sun, G. H. Wang, H. H. Ho, M. Y. Chu, C. Y. Wu, W. L. Jhou, R. S. Tsai, Y. L. Huang, R. T. Sun, K. H. Shye-Jye Tang Shiow-Yi Chen
Issue Date:	Sep-2013
Journal Volume:	52
Journal Issue:	9
Source:	Molecular Carcinogenesis
URI:	http://scholars.ntou.edu.tw/handle/123456789/5347
ISSN:	0899-1987
DOI:	10.1002/mc.21909 ://WOS:000322908900005
Appears in Collections:	生命科學暨生物科技學系

Show full item record

Last Week
0

Last month
0

checked on Oct 13, 2022

Check

DSpace CRIS